Organization
Australian National University, Canberra, Australia
6 abstracts
Abstract
ACHIEVEMENT AND MAINTENANCE OF REMISSION WITH UPADACITINIB IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS IN A REAL-WORLD SETTING: 1-YEAR OUTCOMES FROM THE UPHOLD STUDYOrg: Monash University & Emeritus Research, Melbourne, Victoria, Australia, Australian National University, Canberra, Australia, Helios Department of Rheumatology and Clinical Immunology, Vogelsang-Gommern, Germany, Faculty of Medicine, University of Crete, Heraklion, Greece, Service de Rhumatologie, Hôpital Cochin, AP-HP.Centre – Université Paris Cité, Paris, France,
Abstract
Association between sledai-2k domains and organ damage accrualOrg: Monash University School of Public Health and Preventive Medicine, Melbourne, Australia, Australia Information Technology Faculty of Medicine Nursing and Health Sciences, Australian National University, Canberra, Australia,
Abstract
AN AUSTRALIAN PERSPECTIVE OF ARTHRITIS SELF MANAGEMENTOrg: Arthritis Foundation of NSW Australia, Education Department, Sydney, NSW, Australia, Australian National University, Canberra, Australia, Stanford Research Centre,
Abstract
ADALIMUMAB (HUMIRA®) IS EFFECTIVE AND SAFE IN TREATING RHEUMATOID ARTHRITIS (RA) IN REAL-LIFE CLINICAL PRACTICE: FINAL SUMMARY OF THE 6610 PATIENTS IN THE REACT STUDYOrg: Charité University Medicine Berlin, Humboldt University of Berlin, Berlin Heals, Germany, Gregorio Marañón University General Hospital,
Abstract
B-LYMPHOCYTE FUNCTION IS ALTERED BY PROTEASE ACTIVATED RECEPTOR-1 Org: Sutton, Laboratory of Tissue Engineering, Institute of Bone and Joint Research, Sydney, Kolling Institute, University of Sydney and Sydney Cancer Centre,
Abstract
ASSOCIATION OF HEALTHY LIFESTYLES WITH ALL-CAUSE AND CAUSE-SPECIFIC MORTALITY AMONG INDIVIDUALS WITH OSTEOARTHRITIS: A PROSPECTIVE COHORT STUDY OF THE UK BIOBANKOrg: Zhujiang Hospital, Southern Medical University, Clinical Research Centre, Guangzhou JOYO Pharma, China National Biotec Group,